Consensus-Based Overarching Principles and Recommendations on the Use of Biosimilars in the Treatment of Inflammatory Arthritis in the Gulf Region.

Khalid A Alnaqbi Nasra K Al Adhoubi Sara Ahmad Mohammad Al Dallal Samar Al Emadi Adeeba Al-Herz Amin M El Shamy Suad Hannawi Mohammed A Omair Sahar A Saad Tore K Kvien

Published in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2024)

These are the first consensus recommendations for the Gulf region based on a systematic literature review and Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) guidelines, integrating clinical evidence with clinical expertise to optimize decision making for the use of biosimilars in patients with inflammatory arthritis. They were formulated based on predominantly international data because of the limited regional data and therefore can be generalized to serve as recommendations for healthcare professionals in other parts of the world.

Keyphrases

clinical practice
rheumatoid arthritis
decision making
electronic health record
oxidative stress
big data
emergency department
machine learning